LANDSCAPE OF TARGETABLE BRAF ALTERATIONS AND RAF1 FUSIONS IN PEDIATRIC MALIGNANCY

被引：0

作者：

Rankin, Andrew ^{[1
]}

Johnson, Adrienne ^{[1
]}

Rosenzweig, Mark ^{[1
]}

Knipstein, Jeffrey ^{[1
]}

Kannan, Geoffrey ^{[1
]}

Britt, Nicholas ^{[1
]}

Pavlick, Dean ^{[1
]}

Vergilio, Jo-Anne ^{[1
]}

Severson, Eric ^{[1
]}

Erlich, Rachel ^{[1
]}

Squillace, Rachel ^{[1
]}

Stephens, Phil ^{[1
]}

Miller, Vince ^{[1
]}

Ross, Jeffrey ^{[1
]}

Ramkissoon, Shakti ^{[1
]}

Ali, Siraj ^{[1
]}

机构：

[1] Fdn Med Inc, Cambridge, MA USA

来源：

PEDIATRIC BLOOD & CANCER | 2018年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

801

引用

页数：2

共 45 条

[31] Two cases of spindle cell tumors with S100 and CD34 co-expression showing novel RAF1 fusions
Li-Hua Gong
Wei-Feng Liu
Xiao-Hui Niu
Yi Ding
Diagnostic Pathology, 17
[32] Small cell lung carcinoma harbors targetable alterations including MYCL1 fusions responding to aurora kinase inhibitor
Ali, S.
Kolla, B.
Bailey, M.
Schrock, A. B.
Klempner, S. J.
Frampton, G. M.
Fabrizio, D. A.
Ou, S-H. I.
He, J.
Suh, J.
Ross, J. S.
Stephens, P.
Miller, V.
Patel, M.
ANNALS OF ONCOLOGY, 2016, 27
[33] A Novel Targetable RAF1-QKI Fusion in Adult Spinal Pleomorphic Xanthoastrocytoma without BRAF V600E Mutation
Daoud, Elena
Richardson, Timothy
Mella, Divya
Pan, Edward
Schwarzbach, Anna
White, Charles, III
Hatanpaa, Kimmo
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2018, 77 (06): : 497 - 497
[34] An RNAi-based system for loss-of-function analysis: Identification of Raf1 but not BRAF as a crucial mediator of BCR-ABL-driven leukemogenesis
Albers, C.
Illert, A. L.
Leischner, H.
Miething, C.
Peschel, C.
Duyster, J.
ONKOLOGIE, 2012, 35 : 170 - 170
[35] Acteoside (Verbascoside): A Prospective Therapeutic Alternative against Hepatocellular Carcinoma by Inhibiting the Expression of AXL, FGFR, BRAF, TIE2 and RAF1 Targets
Kityania, Sibashish
Nath, Rajat
Nath, Deepa
Patra, Jayanta Kumar
Das Talukdar, Anupam
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (10) : 1907 - 1919
[36] Transcription Defects in SF3B1K700E Induce Targetable Alterations in the Chromatin Landscape
Boddu, Prajwal
Gupta, Abhishek
Roy, Rahul
Herrero, Anne Olazabal
Verma, Amit
Neugebauer, Karla
Pillai, Manoj
BLOOD, 2023, 142
[37] Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape
Boddu, Prajwal C.
Gupta, Abhishek K.
Roy, Rahul
Avalos, Barbara De La Pena
Olazabal-Herrero, Anne
Neuenkirchen, Nils
Zimmer, Joshua T.
Chandhok, Namrata S.
King, Darren
Nannya, Yasuhito
Ogawa, Seishi
Lin, Haifan
Simon, Matthew D.
Dray, Eloise
Kupfer, Gary M.
Verma, Amit
Neugebauer, Karla M.
Pillai, Manoj M.
MOLECULAR CELL, 2024, 84 (08) : 1475 - 1495.e18
[38] FUNCTIONAL CHARACTERIZATION AND EFFECTIVE TARGETING OF NRF1-BRAF AND ATG7-RAF1 FUSIONS IDENTIFIED IN ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA PATIENTS WITHOUT BRAF P.V600E MUTATION
Sonawane, Poonam
Diviney, Patrick
Phillips, Joanna
Jain, Payal
Storm, Phillip
Resnick, Adam
Waanders, Angela
NEURO-ONCOLOGY, 2018, 20 : 116 - 116
[39] A phase 2 basket trial of an ERK1/2 inhibitor (LY3214996) in combination with abemaciclib for patients whose tumors harbor pathogenic alterations in BRAF, RAF1, MAP2K1/2 ERK1/2, and NF1.
Taza, Fadi
Durm, Greg Andrew
Opyrchal, Mateusz
Jalal, Shadia Ibrahim
Radovich, Milan
Schneider, Bryan P.
Turk, Anita Ahmed
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[40] Expanding the Spectrum of the Soft Tissue Tumors with Kinase Gene Fusions: A Pediatric Spindle Cell Neoplasm Harboring MTAP-RAF1 Fusion
Dogukan, Fatih Mert
Erdem, Zeynep Betuel
Danyeli, Ayca Ersen
FETAL AND PEDIATRIC PATHOLOGY, 2023, 42 (03) : 512 - 517

← 1 2 3 4 5 →